Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Sep 2024
Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%
Read Full NewsA secondary analysis of the DISTAL trial found endovascular therapy's benefit depended more on stroke severity than on prior thrombolysis treatment.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.
A Canadian cohort found modestly greater preeclampsia risk after donation, though most pregnancies were uncomplicated.
Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk.
Sparsentan Lowers Inflammatory, Complement Biomarkers in IgAN
Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant
1.
FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test
2.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
3.
Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.
4.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
5.
The need for more Latinx participants in Alzheimer's trials is urgent.
1.
Molecular Glues for Solid Tumors: Mechanistic Insights, Clinical Relevance, and Therapeutic Potential
2.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
3.
How Cancer Cells Evade Immune Destruction and the Fight Back
4.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
5.
Drug Safety Through Oncology Survivorship Medication Monitoring Frameworks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Navigating the Complexities of Ph Negative ALL - Part X
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge